SCHEMBL9998113

SCHEMBL9998113

CC(=O)OC(OC(C)=O)C(=Cc1cccc(C(C)C)c1)Cc1ccccc1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSHR P16473 1/20 0.41
CNR2 P34972 1/20 0.39
PPARG P37231 1/20 0.39
CYP3A4 P08684 2/20 0.38
CYP2C9 P11712 1/20 0.38
ALDH1A1 P00352 2/20 0.37
BCHE P06276 1/20 0.36
MRGPRX4 Q96LA9 1/20 0.36
LMNA P02545 1/20 0.36
PKM P14618 1/20 0.36
HTT P42858 1/20 0.36
RXRA P19793 1/20 0.35
RXRB P28702 1/20 0.35
RXRG P48443 1/20 0.35
EGFR P00533 1/20 0.35
CRHBP P24387 1/20 0.35
CRHR2 Q13324 1/20 0.35
MEN1 O00255 1/20 0.35
KMT2A Q03164 1/20 0.35
HSD17B10 Q99714 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9998025 0.87 CYP3A4 (0.50) TSHRCNR2CYP3A4CYP2C9ALDH1A1
SCHEMBL9998023 0.87 CYP3A4 (0.50) TSHRCNR2CYP3A4CYP2C9ALDH1A1
SCHEMBL9997711 0.86 TSHR (0.42) TSHRCNR2CYP3A4CYP2C9ALDH1A1
SCHEMBL9997839 0.86 TSHR (0.42) TSHRPPARGCYP3A4CYP2C9ALDH1A1
SCHEMBL9997837 0.86 TSHR (0.42) TSHRPPARGCYP3A4CYP2C9ALDH1A1
SCHEMBL9997710 0.86 TSHR (0.42) TSHRCNR2CYP3A4CYP2C9ALDH1A1
SCHEMBL9998436 0.86 CNR2 (0.48) TSHRCNR2CYP3A4CYP2C9ALDH1A1
SCHEMBL9998417 0.85 CNR2 (0.42) TSHRCNR2PPARGCYP3A4CYP2C9
SCHEMBL9997934 0.85 ALDH1A1 (0.44) TSHRCYP3A4CYP2C9ALDH1A1PKM
SCHEMBL9997932 0.85 ALDH1A1 (0.44) TSHRCYP3A4CYP2C9ALDH1A1PKM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8558012-B2 2-fluoro-1,3-benzodithiol 1,1,3,3-tetraoxide derivative, production method thereof, and production method of monofluoromethyl group-containing compound using the same NAGOYA INSTITUTE OF TECHNOLOGY (JP) 2013-10-15 US disclosed
US-20110319637-A1 2-FLUORO-1,3-BENZODITHIOL 1,1,3,3-TETRAOXIDE DERIVATIVE, PRODUCTION METHOD THEREOF, AND PRODUCTION METHOD OF MONOFLUOROMETHYL GROUP-CONTAINING COMPOUND USING THE SAME NAGOYA INSTITUTE OF TECHNOLOGY (JP) 2011-12-29 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110319637-A1 2-FLUORO-1,3-BENZODITHIOL 1,1,3,3-TETRAOXIDE DERIVATIVE, PRODUCTION METHOD THEREOF, AND PRODUCTION METHOD OF MONOFLUOROMETHYL GROUP-CONTAINING COMPOUND USING THE SAME CBR1, CYP1B1, CYP2F1 TSHR 621/4885CNR2 1173/4885PPARG 2160/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.